Search Results - "Giebeler, A"

Dynamic changes in gene expression after “in situ-split” liver resection by Winnand, P, Giebeler, A, Boekschoten, M, Cramer, T, Neumann, U

Get full text

Prediction of Relative Risks of Radiogenic Second Cancer and Cardiac Toxicity for 17 Pediatric Medulloblastoma Patients Treated With Photon or Proton Craniospinal Irradiation by Zhang, R, Howell, R, Taddei, P, Giebeler, A, Mahajan, A, Newhauser, W

Get full text

SU‐E‐T‐283; Risks of Cardiac Toxicity in Pediatric Patients Receiving Photon Or Proton Radiotherapy by Zhang, R, Howell, R, Homann, K, Giebeler, A, Taddei, P, Mahajan, A, Newhauser, W

“…Purpose: To compare the predicted risk of developing radiogenic cardiac toxicity after photon versus proton radiotherapies for a pediatric patient with Hodgkin…”
Get full text

1352 THE HGF RECEPTOR C-MET IS PROTECTIVE DURING ACUTE UND CHRONIC LIVER INJURY by Kaldenbach, M, Corsten, E, Kroy, D, Giebeler, A, Erschfeld, S, Trautwein, C, Streetz, K.L

Get full text

SU‐E‐T‐257: Risk of Radiogenic Second Cancer after Photon and Proton Craniospinal Irradiation by Zhang, R, Howell, R, Giebeler, A, Taddei, P, Mahajan, A, Newhauser, W

“…Purpose: To compare proton and photon therapies in terms of the risks of second cancers for a pediatric medulloblastoma patient receiving craniospinal…”
Get full text

SU‐C‐BRB‐01: Radiogenic Second Cancer Risk Differences in Female Hodgkin Lymphoma Patients Treated with Proton versus Photon Radiotherapies by Homann, K, Howell, R, Giebeler, A, Eley, J, Randeniya, K, Newhauser, W

“…Purpose: To determine the significance of neutron and scatter dose in comparing the predicted risk of developing a radiogenic second cancer (RSC) to the breast…”
Get full text

690 THE HEPATIC ANTIBACTERIAL RESPONSE DURING CHOLESTATIC LIVER INJURY IS REGULATED VIA GP130 AND C-MET DEPENDENT PATHWAYS by Giebeler, A, Brandenburg, L.O, Erschfeld, S, Kaldenbach, M, Birchmeier, C, Trautwein, C, Streetz, K

Get full text

SU‐E‐T‐276: Equivalent Dose in Children Receiving Craniospinal Irradiation with Photons in a Developing Country Or with Protons in a Developed Country by Taddei, PJ, Khater, N, Youssef, B, Jalbout, W, Howell, RM, Mahajan, A, Zhang, R, Mirkovic, D, Giebeler, A, Geara, FB, Newhauser, WD

“…Purpose: Childhood cancer survivors who were treated with craniospinal irradiation (CSI) have a high risk of radiogenic late effects, for example second…”
Get full text

SU‐E‐T‐47: A Method to Increase Statistical Power in Micro‐Clinical Trials for Second Cancers Following Advanced Techniques for Pediatric Radiotherapy by Giebeler, A, Howell, R, Zhang, R, Etzel, C, Mahajan, A, Newhauser, W

“…Purpose: Pediatric patients are uniquely sensitive to radiation; thus there is specific interest in their risk for second cancers (SCs) following radiotherapy…”
Get full text

SU‐E‐T‐43: Calculation of the Risks of Second Cancer and Cardiac Toxicities for a Pediatric Patient Treated with Photon and Proton Radiotherapies by Zhang, R, Howell, R, Giebeler, A, Taddei, P, Mahajan, A, Newhauser, W

“…Purpose: Although advanced radiation treatment methods deliver highly conformal primary dose, they will expose patients to stray radiation doses, which…”
Get full text

46 INHIBITION OF HGF/C-MET AND NEMO-DEPENDENT SIGNALLINGS PATHWAYS ARE CRUCIAL FOR ENGRAFTMENT AND POSITIVE CELL SELECTION AFTER HEPATOCYTE TRANSPLANTATION by Kaldenbach, M, Tschaharganeh, D.F, Erschfeld, S, Giebeler, A, Chaudhary, K, Birchmeier, C, Liedtke, C, Trautwein, C, Streetz, K.L

Get full text

936 C-MET AND GP130 MEDIATE ANTIBACTERIAL SIGNALLING DURING CHOLESTATIC LIVER INJURY VIA TLR4 AND THE INDUCTION OF THE ACUTE-PHASE RESPONSE by Giebeler, A, Kaldenbach, M, Erschfeld, S, Birchmeier, C, Trautwein, C, Streetz, K

Get full text

946 THE HGF/C-MET SYSTEM PLAYS A CENTRAL ROLE FOR LIVER REPOPULATION BY TRANSPLANTED HEPATOCYTES by Kaldenbach, M, Tschaharganeh, D.F, Erschfeld, S, Giebeler, A, Birchmeier, C, Trautwein, C, Streetz, K.L

Get full text

MO‐G‐BRC‐01: Comparison of the Risk of Second Malignant Neoplasm in a Developed Country versus a Developing Country for a 13‐Year‐Old Girl Receiving Craniospinal Irradiation by Taddei, P J, Jalbout, W, Khater, N, Geara, F B, Mirkovic, D, Howell, R M, Zhang, R, Giebeler, A, Mahajan, A, Newhauser, W D

“…Purpose: Childhood cancer is a global health problem that affects nations of every socioeconomic status. The incidence of treatment‐induced second malignant…”
Get full text

SU‐FF‐T‐625: Estimation of Uncertainty for the Patient and Compensator Scatter Correction Factor in Proton Therapy D/MU Calculations by Giebeler, A, Zhu, X, Starkschall, G, Balter, P, Titt, U, Tucker, S, Newhauser, W

“…Purpose: Interest in the tissue sparing benefit of proton therapy is growing. For lung and prostate cancer patients specifically, studies have shown that…”
Get full text

TU‐FF‐A2‐06: MVCT May Reduce Proton Range Errors in Treatment Plans for Patients with Metal Implants by Newhauser, W, Giebeler, A, Langen, K, Mohan, R

“…Purpose: Treatment planning calculations for proton therapy require accurate knowledge of radiological pathlength, or range, to the distal edge of the target…”
Get full text

SU‐FF‐T‐457: Second Cancer Risk From Secondary Neutrons for a Boy Who Received Proton Craniospinal Irradiation by Taddei, PJ, Mirkovic, D, Fontenot, JD, Giebeler, A, Zheng, Y, Kornguth, D, Mohan, R, Newhauser, WD

“…Purpose: Proton fields used in radiotherapy expose healthy tissue to secondary neutrons emanating from the treatment unit (or “external neutrons”) and produced…”
Get full text

Risk Estimate of Second Malignant Neoplasm Incidence and Mortality from Secondary Neutrons for Two Children Who Received Proton Craniospinal Irradiation by Taddei, P.J, Mirkovic, D, Mahajan, A, Kornguth, D, Giebeler, A, Zhang, R, Harvey, M.C, Woo, S, Newhauser, W.D

Get full text

TU‐C‐AUD B‐04: Dose Perturbations Caused by Implanted Helical Gold Markers Used in Patients Receiving Proton Radiation Therapy for Prostate Cancer by Giebeler, A, Fontenot, J, Balter, P, Ciangaru, G, Zhu, X, Newhauser, W

“…Purpose: Implanted gold fiducial markers are widely used in radiation therapy to improve targeting accuracy; however recent investigations have revealed that…”
Get full text

663 C-MET IN HEPATOCYTES IS PROTECTIVE AGAINST CHOLESTATIC LIVER INJURY AND FIBROSIS PROGRESSION VIA ANTI-APOPTOTIC PATHWAYS IN MICE by Giebeler, A, Klein, C, Boekschoten, M, Borowiak, M, Birchmeier, C, Mueller, M, Trautwein, C, Streetz, K

Get full text